Relationship between stimulated prolactin release from GH cells and cyclic AMP degradation and formation
- PMID: 6281098
- DOI: 10.1016/0303-7207(82)90118-6
Relationship between stimulated prolactin release from GH cells and cyclic AMP degradation and formation
Abstract
We have studied the relationship between the prolaction (PRL) release induced by thyroliberin (TRH) and theophylline and the formation and inactivation of adenosine 3', 5'-cyclic monophosphate (cyclic AMP) in cultured rat-pituitary cells (GH3 cells). TRH, which stimulated prolactin release, increased cyclic AMP formation and stimulated transiently both the low- and high-Km cyclic phosphodiesterases. The maximal effect on the phosphodiesterase was observed at 30 mM TRH. The stimulatory effect of TRH on the activity of the cyclic AMP phosphodiesterases was duplicated by incubation of the cells with cyclic AMP (2-10 mM). In washed particulate GH3 cell fractions, TRH increased the adenylyl cyclase activity up to 180%. Treatment of GH3 cells with theophylline stimulated the release of PRL and inhibited cyclic AMP degradation probably leading to the measured increase in cellular concentrations of the nucleotide. The effects of TRH and theophylline on cellular cyclic AMP concentrations and on PRL release were additive. There was a positive correlation between PRL release and cellular cyclic AMP concentration (r = 0.97). The elevations observed in cellular cyclic AMP concentration after TRH treatment are due to increased formation which in turn leads to phosphodiesterase activation. Therefore, cyclic AMP formation appears to be an intermediary step in the stimulus-secretion coupling caused by the tripeptide.
Similar articles
-
Effects of trifluoperazine on prolactin release and cyclic AMP formation and degradation in GH4C1 pituitary cells.Acta Endocrinol (Copenh). 1987 Sep;116(1):27-35. doi: 10.1530/acta.0.1160027. Acta Endocrinol (Copenh). 1987. PMID: 2821717
-
The pharmacodynamic action of the cyclic AMP phosphodiesterase inhibitor rolipram on prolactin producing rat pituitary adenoma (GH4C1) cells.Biosci Rep. 1990 Aug;10(4):375-88. doi: 10.1007/BF01117237. Biosci Rep. 1990. PMID: 2174276
-
Adenylyl cyclase and cyclic nucleotide phosphodiesterases in GH-Strains of rat pituitary cells.Endocrinology. 1977 Apr;100(4):934-44. doi: 10.1210/endo-100-4-934. Endocrinology. 1977. PMID: 189995
-
The mechanisms by which vasoactive intestinal peptide (VIP) and thyrotropin releasing hormone (TRH) stimulate prolactin release from pituitary cells.Biosci Rep. 1990 Apr;10(2):189-99. doi: 10.1007/BF01116578. Biosci Rep. 1990. PMID: 2162702 Review.
-
Regulation of intracellular cyclic AMP concentrations in hepatocytes involves the integrated activation and desensitization of adenylyl cyclase coupled with the action and activation of specific isoforms of cyclic AMP phosphodiesterase.Biochem Soc Trans. 1992 Feb;20(1):140-6. doi: 10.1042/bst0200140. Biochem Soc Trans. 1992. PMID: 1321746 Review. No abstract available.
Cited by
-
Adenosine 3',5'-cyclic monophosphate-dependent release of prolactin from GH3 pituitary tumour cells. A quantitative analysis.Biochem J. 1983 Dec 15;216(3):551-7. doi: 10.1042/bj2160551. Biochem J. 1983. PMID: 6199014 Free PMC article.
-
In vivo assessment of local phosphodiesterase activity using tailored cyclic nucleotide-gated channels as cAMP sensors.J Gen Physiol. 2001 Jul;118(1):63-78. doi: 10.1085/jgp.118.1.63. J Gen Physiol. 2001. PMID: 11429444 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical